VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABCL icon
301
AbCellera Biologics
ABCL
$1.26B
$174K 0.08%
8,664
-447
-5% -$8.98K
ARQT icon
302
Arcutis Biotherapeutics
ARQT
$2.06B
$174K 0.08%
7,304
-388
-5% -$9.24K
SAVA icon
303
Cassava Sciences
SAVA
$104M
$174K 0.08%
2,798
-153
-5% -$9.52K
CRDF icon
304
Cardiff Oncology
CRDF
$144M
$172K 0.08%
25,770
-1,344
-5% -$8.97K
IMVT icon
305
Immunovant
IMVT
$2.99B
$172K 0.08%
19,794
-1,033
-5% -$8.98K
KRYS icon
306
Krystal Biotech
KRYS
$4.35B
$172K 0.08%
3,288
-167
-5% -$8.74K
INO icon
307
Inovio Pharmaceuticals
INO
$148M
$171K 0.08%
1,988
-104
-5% -$8.95K
SRNE
308
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$171K 0.08%
22,465
-1,181
-5% -$8.99K
KRON
309
DELISTED
Kronos Bio
KRON
$170K 0.07%
8,126
-428
-5% -$8.95K
KURA icon
310
Kura Oncology
KURA
$713M
$170K 0.07%
9,091
-481
-5% -$9K
RPTX icon
311
Repare Therapeutics
RPTX
$72.6M
$170K 0.07%
6,482
-346
-5% -$9.07K
RVMD icon
312
Revolution Medicines
RVMD
$7.57B
$169K 0.07%
6,150
-321
-5% -$8.82K
AKBA icon
313
Akebia Therapeutics
AKBA
$785M
$168K 0.07%
58,243
-3,041
-5% -$8.77K
ANNX icon
314
Annexon
ANNX
$238M
$168K 0.07%
9,043
-472
-5% -$8.77K
BTAI icon
315
BioXcel Therapeutics
BTAI
$55.2M
$168K 0.07%
347
-17
-5% -$8.23K
PSTX
316
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$168K 0.07%
23,082
-1,205
-5% -$8.77K
SWTX
317
DELISTED
SpringWorks Therapeutics
SWTX
$167K 0.07%
2,640
-134
-5% -$8.48K
BOLT icon
318
Bolt Biotherapeutics
BOLT
$9.96M
$165K 0.07%
651
-34
-5% -$8.62K
RAPT icon
319
RAPT Therapeutics
RAPT
$214M
$165K 0.07%
664
-35
-5% -$8.7K
SGMO icon
320
Sangamo Therapeutics
SGMO
$165M
$163K 0.07%
18,086
-951
-5% -$8.57K
ZYME icon
321
Zymeworks
ZYME
$1.14B
$163K 0.07%
5,597
-297
-5% -$8.65K
CMPS
322
Compass Pathways
CMPS
$493M
$162K 0.07%
5,439
-285
-5% -$8.49K
CLVS
323
DELISTED
Clovis Oncology, Inc.
CLVS
$162K 0.07%
36,410
-1,893
-5% -$8.42K
SYRS
324
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$161K 0.07%
3,609
-189
-5% -$8.43K
KDNY
325
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$161K 0.07%
12,632
-667
-5% -$8.5K